Novel compound C150 inhibits pancreatic cancer through induction of ER stress and proteosome assembly

Overview of attention for article published in Frontiers in oncology, October 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 7 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 32,560 followers.

Novel compound C150 inhibits pancreatic cancer through induction of ER stress and proteosome assembly https://t.co/X3dtUBu1vu https://t.co/ETK0dzn5Sf

25 Oct 2022

Reply Repost Favourite

RT @DrImranSheikh: Novel compound C150 inhibits pancreatic cancer through induction of ER stress and proteosome assembly: Pancreatic cancer…

06 Oct 2022

Reply Repost Favourite

Novel compound C150 inhibits pancreatic cancer through induction of ER stress and proteosome assembly: Pancreatic cancer is a devastating disease with a dismal prognosis and poor treatment outcomes. Searching for new agents for… #oncology https://t.co/5yf

06 Oct 2022

Reply Repost Favourite

New research: Novel compound C150 inhibits pancreatic cancer through induction of ER stress and proteosome assembly: Pancreatic cancer is a devastating disease with a dismal prognosis and poor treatment outcomes. Searching for new agents for… https://t.co/

05 Oct 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.